|
1
|
Nagai MA and Brentani MM: Gene expression
profiles in breast cancer to identify estrogen receptor target
genes. Mini Rev Med Chem. 8:448–454. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ko YJ and Balk SP: Targeting steroid
hormone receptor pathways in the treatment of hormone dependent
cancers. Curr Pharm Biotechnol. 5:459–470. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zimmermann J and von Angerer E: Estrogenic
and antiestrogenic activities of 2,4-diphenylfuran-based ligands of
estrogen receptors alpha and beta. J Steroid Biochem Mol Biol.
104:259–268. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dunn CA, Clark W, Black EJ and Gillespie
DA: Estrogen receptor activation function 2 (AF-2) is essential for
hormone-dependent transactivation and cell transformation induced
by a v-Jun DNA binding domain-estrogen receptor chimera. Biochim
Biophys Acta. 1628:147–155. 2003. View Article : Google Scholar
|
|
5
|
Couse JF, Lindzey J, Grandien K,
Gustafsson JA and Korach KS: Tissue distribution and quantitative
analysis of estrogen receptor-α (ER-α) and estrogen receptor-α
(ER-α) messenger ribonucleic acid in the wild-type and ER-α
knockout mouse. Endocrinology. 11:353–365. 1997.
|
|
6
|
Shen R, Tao L, Xu Y, Chang S, Van Brocklyn
J and Gao JX: Reversibility of aberrant global DNA and estrogen
receptor-alpha gene methylation distinguishes colorectal precancer
from cancer. Int J Clin Exp Pathol. 2:21–33. 2009.PubMed/NCBI
|
|
7
|
Maynadier M, Nirde P, Ramirez JM, Cathiard
AM, Platet N, Chambon M and Garcia M: Role of estrogens and their
receptors in adhesion and invasiveness of breast cancer cells. Adv
Exp Med Biol. 617:485–491. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Somlo G, Frankel P, Chow W, Leong L,
Margolin K, Morgan R Jr, Shibata S, Chu P, Forman S, Lim D, et al:
Prognostic indicators and survival in patients with stage IIIB
inflammatory breast carcinoma after dose-intense chemotherapy. J
Clin Oncol. 22:1839–1848. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ha SA, Lee YS, Shin SM, et al: Oncoprotein
HCCR-1 expression in breast cancer is well correlated with known
breast cancer prognostic factors including the HER2 overexpression,
p53 mutation, and ER/PR status. BMC Cancer. 9:512009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bilalović N, Vranić S, Hasanagić S, Basić
H, Tatarević A, Beslija S and Selak I: The Bcl-2 protein: a
prognostic indicator strongly related to ER and PR in breast
cancer. Bosn J Basic Med Sci. 4:5–12. 2004.PubMed/NCBI
|
|
11
|
Kawai H, Ishii A, Washiya K, Konno T, Kon
H, Yamaya C, Ono I and Ogawa J: Combined overexpression of EGFR and
estrogen receptor alpha correlates with a poor outcome in lung
cancer. Anticancer Res. 25:4693–4698. 2005.PubMed/NCBI
|
|
12
|
Giovannini M, Belli C, Villa E and Gregorc
V: Estrogen receptor (ER) and epidermal growth factor receptor
(EGFR) as targets for dual lung cancer therapy: not just a case? J
Thorac Oncol. 3:684–685. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Messina M, McCaskill-Stevens W and Lampe
JW: Addressing the soy and breast cancer relationship: review,
commentary, and workshop proceedings. J Natl Cancer Inst.
98:1275–1284. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou JR, Yu L, Mai Z and Blackburn GL:
Combined inhibition of estrogen-dependent human breast carcinoma by
soy and tea bioactive components in mice. Int J Cancer. 108:8–14.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Boyapati SM, Shu XO, Ruan ZX, Cai Q, Smith
JR, Wen W, Gao YT and Zheng W: Polymorphisms in ER-alpha gene
interact with estrogen receptor status in breast cancer survival.
Clin Cancer Res. 11:1093–1098. 2005.PubMed/NCBI
|
|
16
|
Hu Z, Song CG, Lu JS, Luo JM, Shen ZZ,
Huang W and Shao ZM: A multigenic study on breast cancer risk
associated with genetic polymorphisms of ER alpha, COMT and CYP19
gene in BRCA1/BRCA2 negative Shanghai women with early onset breast
cancer or affected relatives. J Cancer Res Clin Oncol. 133:969–978.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sobczuk A, Pertynski T, Smolarz B and
Romanowicz-Makowska H: The analysis of estrogen receptor alpha
(ER-alpha) gene Pvull and Xbal polymorphisms in postmenopausal
women with breast cancer. Pol Merkur Lekarski. 25:43–45.
2008.PubMed/NCBI
|
|
18
|
Onland-Moret NC, van Gils CH, Roest M,
Grobbee DE and Peeters PH: The estrogen receptor alpha gene and
breast cancer risk (The Netherlands). Cancer Causes Control.
16:1195–1202. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shin A, Kang D, Nishio H, et al: Estrogen
receptor alpha gene polymorphisms and breast cancer risk. Breast
Cancer Res Treat. 80:127–131. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Marquez-Garban DC, Chen HW, Fishbein MC,
Goodglick L and Pietras RJ: Estrogen receptor signaling pathways in
human non-small cell lung cancer. Steroids. 72:135–143. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schwartz AG, Wenzlaff AS, Prysak GM,
Murphy V, Cote ML, Brooks SC, Skafar DF and Lonardo F: Reproductive
factors, hormone use, estrogen receptor expression and risk of non
small-cell lung cancer in women. J Clin Oncol. 25:5785–5792. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pietras RJ, Marquez DC, Chen HW, Tsai E,
Weinberg O and Fishbein M: Estrogen and growth factor receptor
interactions in human breast and non-small cell lung cancer cells.
Steroids. 70:372–381. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kawai H, Ishii A, Washiya K, Konno T, Kon
H, Yamaya C, Ono I, Minamiya Y and Ogawa J: Estrogen receptor alpha
and beta are prognostic factors in non-small cell lung cancer. Clin
Cancer Res. 11:5084–5089. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mollerup S, Jorgensen K, Berge G and
Haugen A: Expression of estrogen receptors alpha and beta in human
lung tissue and cell lines. Lung Cancer. 37:153–159. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Department of Health (DOH). 2010
statistics of causes of death, DOH, Executive Yuan, R.O.C.
(Taiwan). 2011
|
|
26
|
Stabile LP and Siegfried JM: Estrogen
receptor pathways in lung cancer. Curr Oncol Rep. 6:259–267. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stabile LP, Lyker JS, Gubish CT, Zhang W,
Grandis JR and Siegfried JM: Combined targeting of the estrogen
receptor and the epidermal growth factor receptor in non-small cell
lung cancer shows enhanced antiproliferative effects. Cancer Res.
65:1459–1470. 2005. View Article : Google Scholar
|
|
28
|
Hershberger PA, Vasquez AC, Kanterewicz B,
Land S, Siegfried JM and Nichols M: Regulation of endogenous gene
expression in human non-small cell lung cancer cells by estrogen
receptor ligands. Cancer Res. 65:1598–1605. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai Q, Shu XO, Jin F, Dai Q, Wen W, Cheng
JR, Gao YT and Zheng W: Genetic polymorphisms in the estrogen
receptor alpha gene and risk of breast cancer: results from the
Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev.
12:853–859. 2003.PubMed/NCBI
|
|
30
|
Schupf N, Lee JH, Wei M, Pang D, Chace C,
Cheng R, Zigman WB, Tycko B and Silverman W: Estrogen
receptor-alpha variants increase risk of Alzheimer’s disease in
women with Down syndrome. Dement Geriatr Cogn Disord. 25:476–482.
2008.
|
|
31
|
Nilsson M, Dahlman I, Ryden M, Nordström
EA, Gustafsson JA, Arner P and Dahlman-Wright K: Oestrogen receptor
alpha gene expression levels are reduced in obese compared to
normal weight females. Int J Obes. 31:900–907. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jian WX, Yang YJ, Long JR, Li YN, Deng FY,
Jiang DK and Deng HW: Estrogen receptor alpha gene relationship
with peak bone mass and body mass index in Chinese nuclear
families. J Hum Genet. 50:477–482. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hoshi M, Yasuoka H and Kuwana M: Estrogen
receptor gene polymorphisms in Japanese patients with systemic
sclerosis. Clin Exp Rheumatol. 26:914–917. 2008.PubMed/NCBI
|
|
34
|
Kitawaki J, Kado N, Ishihara H, Koshiba H,
Kitaoka Y and Honjo H: Endometriosis: the pathophysiology as an
estrogen-dependent disease. J Steroid Biochem Mol Biol. 83:149–155.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Massart F, Becherini L, Gennari L,
Facchini V, Genazzani AR and Brandi ML: Genotype distribution of
estrogen receptor-alpha gene polymorphisms in Italian women with
surgical uterine leiomyomas. Fertil Steril. 75:567–570. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Välimäki VV, Piippo K, Välimäki S,
Löyttyniemi E, Kontula K and Välimäki MJ: The relation of the XbaI
and PvuII polymorphisms of the estrogen receptor gene and the CAG
repeat polymorphism of the androgen receptor gene to peak bone mass
and bone turnover rate among young healthy men. Osteoporos Int.
16:1633–1640. 2005.
|
|
37
|
Hill SM, Fuqua SAW, Chamness GC, Greene GL
and McGuire WL: Estrogen receptor expression in human breast cancer
associated with an estrogen receptor gene restriction fragment
length polymorphism. Cancer Res. 49:145–148. 1989.PubMed/NCBI
|
|
38
|
Kamby C, Rose C, Iversen H, Holm NV,
Andersen KW and Thorpe SM: Pattern of metastases in breast cancer
and the relation to estrogen receptor status. Ugeskr Laeger.
148:2546–2548. 1986.PubMed/NCBI
|
|
39
|
Andersen J and Poulsen HS: Relationship
between estrogen receptor status in the primary tumor and its
regional and distant metastases. An immunohistochemical study in
human breast cancer. Acta Oncol. 27:761–765. 1988. View Article : Google Scholar
|
|
40
|
Talman ML, Rasmussen BB, Andersen J and
Christensen IJ: Estrogen receptor analyses in the Danish Breast
Cancer Cooperative Group. History, methods, prognosis and clinical
implications. Acta Oncol. 47:789–794. 2008. View Article : Google Scholar
|
|
41
|
Kitawaki J, Obayashi H, Ishihara H,
Koshiba H, Kusuki I, Kado N, Tsukamoto K, Hasegawa G, Nakamura N
and Honjo H: Oestrogen receptor-alpha gene polymorphism is
associated with endometriosis, adenomyosis and leiomyomata. Hum
Reprod. 16:51–55. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Andersen TI, Heimdal KR, Skrede M, Tveit
K, Berg K and Børresen AL: Oestrogen receptor (ESR) polymorphisms
and breast cancer susceptibility. Hum Genet. 94:665–670.
1994.PubMed/NCBI
|
|
43
|
Weiderpass E, Persson I, Melhus H, Wedrén
S, Kindmark A and Baron JA: Estrogen receptor alpha gene
polymorphisms and endometrial cancer risk. Carcinogenesis.
21:623–627. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kobayashi S, Inoue S, Hosoi T, Ouchi Y,
Shiraki M and Orimo H: Association of bone mineral density with
polymorphism of the estrogen receptor gene. J Bone Miner Res.
11:306–311. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yamada Y, Ando F, Niino N, Ohta S and
Shimokata H: Association of polymorphisms of the estrogen receptor
alpha gene with bone mineral density of the femoral neck in elderly
Japanese women. J Mol Med. 80:452–460. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Niino M, Kikuchi S, Fukazawa T, Yabe I and
Tashiro K: Estrogen receptor gene polymorphism in Japanese patients
with multiple sclerosis. J Neurol Sci. 179:70–75. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kazama H, Ruberu NN, Murayama S, Saito Y,
Nakahara K, Kanemaru K, Nagura H, Arai T, Sawabe M, Yamanouchi H,
et al: Association of estrogen receptor alpha gene polymorphisms
with neurofibrillary tangles. Dement Geriatr Cogn Disord.
18:145–150. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lin GF, Ma QW, Zhang DS, Zha YL, Lou KJ
and Shen JH: Polymorphism of alpha-estrogen receptor and aryl
hydrocarbon receptor genes in dementia patients in Shanghai suburb.
Acta Pharmacol Sin. 24:651–656. 2003.PubMed/NCBI
|
|
49
|
Han KO, Moon IG, Kang YS, Chung HY, Min HK
and Han IK: Nonassociation of estrogen receptor genotypes with bone
mineral density and estrogen responsiveness to hormone replacement
therapy in Korean postmenopausal women. J Clin Endocrinol Metab.
82:991–995. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Koh JM, Nam-Goong IS, Hong JS, Kim HK, Kim
JS, Kim SY and Kim GS: Oestrogen receptor alpha genotype, and
interactions between vitamin D receptor and transforming growth
factor-beta1 genotypes are associated with quantitative calcaneal
ultrasound in postmenopausal women. Clin Endocrinol. 60:232–240.
2004. View Article : Google Scholar
|
|
51
|
Lee YJ, Shin KS, Kang SW, Lee CK, Yoo B,
Cha HS, Koh EM, Yoon SJ and Lee J: Association of the oestrogen
receptor alpha gene polymorphisms with disease onset in systemic
lupus erythematosus. Ann Rheum Dis. 63:1244–1249. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bagger YZ, Jørgensen HL, Heegaard AM,
Bayer L, Hansen L and Hassager C: No major effect of estrogen
receptor gene polymorphisms on bone mineral density or bone loss in
postmenopausal Danish women. Bone. 26:111–116. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Van Meurs JB, Schuit SC, Weel AE, van der
Klift M, Bergink AP, Arp PP, Colin EM, Fang Y, Hofman A, van Duijn
CM, et al: Association of 5' estrogen receptor alpha gene
polymorphisms with bone mineral density, vertebral bone area and
fracture risk. Hum Mol Genet. 12:1745–1754. 2003.
|
|
54
|
Albagha OM, Pettersson U, Stewart A,
McGuigan FE, MacDonald HM, Reid DM and Ralston SH: Association of
oestrogen receptor alpha gene polymorphisms with postmenopausal
bone loss, bone mass, and quantitative ultrasound properties of
bone. J Med Genet. 42:240–246. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Becherini L, Gennari L, Masi L, Mansani R,
Massart F, Morelli A, Falchetti A, Gonnelli S, Fiorelli G, Tanini A
and Brandi ML: Evidence of a linkage disequilibrium between
polymorphisms in the human estrogen receptor alpha gene and their
relationship to bone mass variation in postmenopausal Italian
women. Hum Mol Genet. 9:2043–2050. 2000. View Article : Google Scholar
|
|
56
|
Patel MS, Cole DE, Smith JD, Hawker GA,
Wong B, Trang H, Vieth R, Meltzer P and Rubin LA: Alleles of the
estrogen receptor alpha-gene and an estrogen receptor
cotranscriptional activator gene, amplified in breast cancer-1
(AIB1), are associated with quantitative calcaneal ultrasound. J
Bone Miner Res. 15:2231–2239. 2000. View Article : Google Scholar
|
|
57
|
Jakimiuk A, Nowicka M, Bogusiewicz M,
Adamiak A, Skorupski P, Miotla P, Rechberger T and Haczynski J:
Prevalence of estrogen receptor alpha PvuII and XbaI polymorphism
in population of Polish postmenopausal women. Folia Histochem
Cytobiol. 45:331–338. 2007.PubMed/NCBI
|
|
58
|
Wang Z, Yoshida S, Negoro K, Kennedy S,
Barlow D and Maruo T: Polymorphisms in the estrogen receptor beta
gene but not estrogen receptor alpha gene affect the risk of
developing endometriosis in a Japanese population. Fertil Steril.
81:1650–1656. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Kikuchi S, Fukazawa T, Niino M, Yabe I,
Miyagishi R, Hamada T and Tashiro K: Estrogen receptor gene
polymorphism and multiple sclerosis in Japanese patients:
interaction with HLA-DRB1*1501 and disease modulation. J
Neuroimmunol. 128:77–81. 2002.PubMed/NCBI
|
|
60
|
Georgiou I, Konstantelli M, Syrrou M,
Messinis IE and Lolis DE: Oestrogen receptor gene polymorphisms and
ovarian stimulation for in-vitro fertilization. Hum Reprod.
12:1430–1433. 1997. View Article : Google Scholar : PubMed/NCBI
|
